T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

T-cell MRD Evaluation Using Flow Cytometric Analysis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01078337

Enrollment

Registered

2010-03-02

Start date

2002-11-30

Completion date

2007-10-31

Last updated

2010-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia, Lymphocytic, Acute

Brief summary

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Interventions

PROCEDUREbone marrow aspiration

PROCEDUREperipheral blood sampling

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

* Children with newly diagnosed T-cell ALL

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026